Liabilities / Assets
42nd percentile
Higher debt load relative to assets than 42% of similar nonprofits.
I2B2 Transmart Foundation
990 • Fiscal year 2024 • EIN 80-0912629
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.03x
Liabilities / Revenue
86th percentile
Higher debt load relative to revenue than 86% of similar nonprofits.
Net Margin
1st percentile
Higher net margin than 1% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
6th percentile
Faster asset growth than 6% of similar nonprofits.
Revenue Growth
1st percentile
Faster revenue growth than 1% of similar nonprofits.
Balance Sheet
Assets
Down$1,635,324
Down $535,497 (-25%) from 2023
Net Assets
Down$1,587,548
Down $549,307 (-26%) from 2023
Liabilities
Up$47,776
Up $13,810 (+41%) from 2023
Revenue And Expenses
Revenue
Down$65,030
Down $1,349,015 (-95%) from 2023
Expenses
Down$812,669
Down $102,304 (-11%) from 2023
Net Income
Down-$747,639
Down $1,246,711 (-250%) from 2023
Historical Trend
Filing Detail Status
This 2024 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jul 1, 2023 to Jun 30, 2024
Mission and Program Overview
Mission
The i2b2 transmart foundation enables effective collaboration for precision medicine, through the sharing, integration, standardization and analysis of heterogenous data from healthcare and research; through engagement and mobilization of a life sciences focused open-source, open-data community.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2024 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $1,635,324
- Liabilities
- $47,776
- Net assets
- $1,587,548
- Revenue
- $65,030
- Expenses
- $812,669
- Net income
- -$747,639